Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help ...
Stocktwits on MSN9d
Is Aclarion's Tie-Up With Scripps Health A Lasting Catalyst? Most Retail Traders Think It's A 'Game-Changer'Healthcare technology firm Aclarion Inc.'s (ACON) stock surged nearly 127% on Monday, marking its best single-day gain since ...
Aclarion shares are trading higher by 124% during Monday's session. The company announced it signed a commercial deal with ...
Aclarion, Inc. (NASDAQ:ACON) shares are trading higher premarket on Monday after the company disclosed a commercial ...
Inc trading halted, volatility trading pauseDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are ...
Aclarion (ACON) announced plans to expand Nociscan access across key markets in New York and New Jersey. The expansion plans build on previously established Nociscan sites with RadNet (RDNT ...
Aclarion (ACON) announced plans to expand Nociscan access across key markets in New York and New Jersey. The expansion plans build on previously established Nociscan sites with RadNet (RDNT) ...
Aclarion's new patent extends MRS use for identifying propionic acid as a biomarker for infections and pain beyond intervertebral discs. Aclarion, Inc. has announced the receipt of a Notice of ...
BROOMFIELD, Colo., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc. ("Aclarion" or the "Company") (NASDAQ: ACON) (NASDAQ: ACONW), a healthcare technology company that ...
Aclarion, Inc. (NASDAQ:ACON – Get Free Report) saw a significant increase in short interest in the month of February. As of February 15th, there was short interest totalling 247,100 shares, an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback